Physicians in Finland find that self-care would often suffice

11 January 2016

Physicians find that patients tend to seek medical help also in cases where their health problem could be solved with self-care medicines, according to a posting on trade group Pharma Industry Finland’s (PIF) website.

Over 60% of physicians think that patients are no longer capable of assessing the seriousness of their symptoms. These are among the outcomes of the questionnaire replied by phone by 200 physicians. The study was performed by TNS Gallup for Pharma Industry Finland PIF.

Recently, the analgesic naproxen and the anti-migraine medicine sumatriptan were released for self-care use in Finland. Controlled and safe extension of self-care medication contributes to a more efficient healthcare service.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK